 |
InterPro: IPR008940 Protein prenyltransferase
Additional Reading
|
|
Njoroge FG, Vibulbhan B, Pinto P, Strickland C, Bishop WR, Nomeir A, Girijavallabhan V.
Enhanced FTase activity achieved via piperazine interaction with catalytic zinc.
Bioorg. Med. Chem. Lett. 16 2006 984-8
[PubMed: 16298128]
http://dx.doi.org/10.1016/j.bmcl.2005.10.090
|
|
Van Voorhis WC, Rivas KL, Bendale P, Nallan L, Horney C, Barrett LK, Bauer KD, Smart BP, Ankala S, Hucke O, Verlinde CL, Chakrabarti D, Strickland C, Yokoyama K, Buckner FS, Hamilton AD, Williams DK, Lombardo LJ, Floyd D, Gelb MH.
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.
Antimicrob. Agents Chemother. 51 2007 3659-71
[PubMed: 17606674]
http://dx.doi.org/10.1128/AAC.00246-07
|
|
Reid TS, Long SB, Beese LS.
Crystallographic analysis reveals that anticancer clinical candidate L-778,123 inhibits protein farnesyltransferase and geranylgeranyltransferase-I by different binding modes.
Biochemistry 43 2004 9000-8
[PubMed: 15248757]
http://dx.doi.org/10.1021/bi049280b
|
|
Terry KL, Casey PJ, Beese LS.
Conversion of protein farnesyltransferase to a geranylgeranyltransferase.
Biochemistry 45 2006 9746-55
[PubMed: 16893176]
http://dx.doi.org/10.1021/bi060295e
|
|
Eastman RT, White J, Hucke O, Yokoyama K, Verlinde CL, Hast MA, Beese LS, Gelb MH, Rathod PK, Van Voorhis WC.
Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase.
Mol. Biochem. Parasitol. 152 2007 66-71
[PubMed: 17208314]
http://dx.doi.org/10.1016/j.molbiopara.2006.11.012
|
|
|
InterPro 23.1
|